$LDOS

Leidos Awarded $318 Million Defense Health Agency Contract For MHS GENESIS Support

Leidos (LDOS) won a $318M contract from the Defense Health Agency to support MHS GENESIS, the DoD's electronic health record system. The 12-month contract, starting July 2026, covers system reintegration, software licensing, and hosting services. The agency aims to transition some work to other contractors during this period.

Original reporting
Published Oct 19, 2026, 5:19 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 6:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Leidos Awarded $318 Million Defense Health Agency Contract For MHS GENESIS Support — source image
Decision brief

The 30-second read

$LDOSBullishMed
01

Why it matters

The award secures a near‑term revenue stream and may improve Leidos' win‑rate for future defense health contracts.

02

Market read

A new $318 M contract to a mid‑cap defense contractor is material news that could lift the stock.

03

What to watch

Potential competition from other contractors during the transition period could limit upside.

Relevance 7/10Novelty 9/10Timing: post‑announcement

Background

Leidos (LDOS) is a major U.S. defense and intelligence contractor. The Defense Health Agency's MHS GENESIS is the DoD's electronic health record system.

Company-level read

Ticker impact

$LDOSBullishHigh confidence
Context

Leidos was awarded a $317,986,855 firm‑fixed‑price contract by the Defense Health Agency to support MHS GENESIS.

Expected impact

likely upward pressure as the market prices in the new multi‑hundred‑million contract.

Evidence & confidence

Large, sole‑source award to a mid‑cap defense contractor; revenue boost expected in FY2027.

Market effects

Boosts outlook for defense IT and government contracting sector.

Positive for U.S. defense contractors and related supply chain.

Limited to defense and health‑record technology niche.

Counterpoint

If the contract is a bridge award with decreasing scope, the long‑term revenue impact may be modest.

Key entities

  • Leidos

    U.S. defense and intelligence contractor (ticker LDOS).

  • Defense Health Agency

    U.S. DoD agency overseeing military health services.

Related articles

$LDOSHigh

Leidos (LDOS) Secures $160M Contract to Support U.S. Cyber Comma

Leidos (LDOS) won a $160M contract to support U.S. Cyber Command for five years. The company is seen as modestly undervalued with a 25.7% margin of safety, according to GF Value. Its GF Score is 85/100, reflecting strong growth and profitability. Insider activity shows $3.2M in sales and no purchases over the past year. Leidos operates primarily in government cybersecurity and defense.

$LDOSHigh

Leidos wins $160 million U.S. Cyber Command contract

Leidos (LDOS) secured a $160M contract to support U.S. Cyber Command in cyber operations over five years. The contract includes offensive and defensive cyber operations, threat analysis, and network defense. Leidos will use its recent acquisition, Kudu Dynamics, to fulfill the contract. The company reported $17.2B in annual revenue for 2026.

$LDOSMed

U.S. Cyber Command selects Leidos for full-spectrum cyber operations

Leidos (LDOS) won a $160M contract to support U.S. Cyber Command in cyber operations over five years. The work includes offensive and defensive cyber operations, threat analysis, and network defense. The contract aligns with Leidos' NorthStar 2030 strategy, with cyber as a key growth area. Leidos reported $17.2B in annual revenue for fiscal year 2026.

$LDOSHigh

A $160 million award will have Leidos helping plan and conduct U.S. military cyber operations.

Leidos (LDOS) received a $160 million, five-year contract to plan and conduct U.S. military cyber operations. The company will integrate offensive and defensive cyber operations, including support for the Department of War Information Network. This aligns with Leidos' NorthStar 2030 strategy, positioning cyber as a key growth driver. Leidos reported annual revenues of approximately $16 billion. The company issued forward-looking statements with typical caveats about risks and uncertainties.